印度阿萨姆邦成人单剂乙脑疫苗效果研究(2012-2018)
该研究在印度阿萨姆邦两个地区比较2012-2018年452例实验室确诊住院乙脑患者与904名匹配健康对照的疫苗接种状态,估算单剂乙脑疫苗效果。结果显示7年期内疫苗效果为77.0%(95%CI:67.0-83.0),接种后第1年效果91%,第6年降至71%。成人乙脑发病率从接种前10.5/10万降至接种后5.7/10万,两地区成人疫苗覆盖率40.1%。
要点
- 单剂乙脑疫苗在7年期内效果为77.0%(95%CI:67.0-83.0)
- 疫苗效果从第1年91%降至第6年71%
- 接种后成人乙脑发病率由10.5/10万降至5.7/10万
核心结论
- 单剂乙脑疫苗至少提供6年充分保护。
- 定期开展大规模接种活动可进一步降低阿萨姆邦流行区乙脑发病率。
研究设计与样本
- 病例对照研究:452例实验室确诊住院乙脑患者与904名年龄、性别、地区匹配的健康对照,2012-2018年入组。
- 利用2009-2018年监测数据计算成人乙脑发病率。
- 在Sivasagar和Dibrugarh两地区开展社区调查估算疫苗覆盖率。
主要发现
- 单剂乙脑疫苗7年期内效果为77.0%(95%CI:67.0-83.0)。
- 疫苗效果从接种后第1年91%(95%CI:73.0-97.0)降至第6年71%(95%CI:21.0-90.0)。
- 成人乙脑发病率从接种前10.5/10万降至接种后5.7/10万。
- 两地区成人疫苗覆盖率为40.1%(95%CI:36.8-43.5)。
临床怎么用
- 在乙脑流行区成人中,单剂乙脑疫苗可提供至少6年保护,可考虑定期大规模接种以维持保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Japanese encephalitis virus (JEV) remains the major etiology of encephalitis throughout Asia. In India, the state of Assam alone contributes more than one-third of the national burden of JE. Between 2011 and 2014, a single dose of JE vaccine SA 14-14-2 (LAJEV) was administered among adults aged 15-65 years residing in Sivasagar and Dibrugarh districts of Assam, India. We monitored the trend of JE incidence between 2009 and 2018 using JE surveillance data, estimated the long-term effectiveness of the single dose of LAJEV and estimated the coverage of JE vaccine in two districts. METHODS: We compared the JE vaccination status of laboratory-confirmed hospitalized JE patients (case) and age, sex and locality matched healthy individuals (controls) to estimate the effectiveness of single dose of JE vaccine. We used surveillance data for 2009-2018 to calculate the incidence of JE among adults. We conducted a community-based survey to estimate the coverage of JE vaccine in the two districts. RESULTS: A total of 452 laboratory-confirmed JE case-patients and 904 matched healthy controls were enrolled in the study between 2012 and 2018. The effectiveness of a single dose of JE vaccine over the 7-year period was 77.0 (95% CI: 67.0-83.0). Vaccine effectiveness decreased from 91% (95% CI: 73.0-97.0) in first year of vaccination to 71% (95% CI: 21.0-90.0) at six years post-vaccination. The incidence of adults JE cases declined from 10.5 per 100,000 in the pre-vaccination period to 5.7 per 100,000 in the years following vaccination. The coverage of vaccine among adults in two districts was 40.1% (36.8-43.5). CONCLUSIONS: A single dose of JE vaccine offered adequate protection for at least six years. Conducting mass vaccination campaigns periodically would further reduce the incidence of JE in endemic districts in Assam.
引用
- Khan SA, Choudhury P, Kakati S, et al. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018. Vaccine. 2021. PMID: 34325931. doi:10.1016/j.vaccine.2021.07.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。